Phosphodiesterase type 5 inhibitors: Irrational use in Saudi Arabia

Arab Journal of Urology - Tập 14 - Trang 94-100 - 2016
Saad Alshahrani1, Abul-Fotouh Ahmed1,2, Ahmed H. Gabr1,3, Ahmed Al Ansari4, Mohamed El-feky2, Mohamed S. Elbadry3
1Department of Urology, College of Medicine, Prince Sattam Bin Abdulaziz University, Saudi Arabia
2Department of Urology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
3Department of Urology, Faculty of Medicine, Minia University, Minia, Egypt
4Bahrain Defence Force Hospital, Department of Surgery, Arabian Gulf University, Bahrain

Tài liệu tham khảo

10.1001/jama.1993.03510010089036 10.1016/S0022-5347(17)34871-1 10.1111/j.1743-6109.2008.00773.x 10.1111/j.1743-6109.2004.10108.x Smith K.M., 2003, J Am Pharm Assoc, 2005, 63 10.1111/j.1743-6109.2007.00460.x 10.1136/bmj.318.7184.669 10.1111/j.1743-6109.2008.00792.x 10.1038/sj.ijir.3900472 10.1016/S0022-5347(08)60996-9 10.1111/j.1743-6109.2010.01965.x 10.1111/j.1743-6109.2012.02755.x 10.1590/S0034-89102008000500024 10.1016/j.jadohealth.2005.12.021 10.1097/00002030-200207050-00017 10.1038/sj.ijir.3901584 10.1038/sj.ijir.3901005